Request for Covid-19 Impact Assessment of this Report
The United States Estrogen Receptor Beta market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Estrogen Receptor Beta market, reaching US$ million by the year 2028. As for the Europe Estrogen Receptor Beta landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Estrogen Receptor Beta players cover Acadia Pharmaceuticals Inc, AstraZeneca Plc, Atossa Genetics Inc, and Chamaeleo Pharma NV, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Estrogen Receptor Beta market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Erteberel
Estetrol
Fosfestrol
Fulvestrant
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Women's Health
Metabolic Disorder
Dermatology
Immunology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Acadia Pharmaceuticals Inc
AstraZeneca Plc
Atossa Genetics Inc
Chamaeleo Pharma NV
Eli Lilly and Company
Endece LLC
EndoCeutics Inc
Karo Pharma AB
Kissei Pharmaceutical Co Ltd
MEI Pharma Inc
Mithra Pharmaceuticals SA
Oasmia Pharmaceutical AB
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Estrogen Receptor Beta Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Estrogen Receptor Beta by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Estrogen Receptor Beta by Country/Region, 2017, 2022 & 2028
2.2 Estrogen Receptor Beta Segment by Type
2.2.1 Erteberel
2.2.2 Estetrol
2.2.3 Fosfestrol
2.2.4 Fulvestrant
2.2.5 Others
2.3 Estrogen Receptor Beta Sales by Type
2.3.1 Global Estrogen Receptor Beta Sales Market Share by Type (2017-2022)
2.3.2 Global Estrogen Receptor Beta Revenue and Market Share by Type (2017-2022)
2.3.3 Global Estrogen Receptor Beta Sale Price by Type (2017-2022)
2.4 Estrogen Receptor Beta Segment by Application
2.4.1 Women's Health
2.4.2 Metabolic Disorder
2.4.3 Dermatology
2.4.4 Immunology
2.4.5 Others
2.5 Estrogen Receptor Beta Sales by Application
2.5.1 Global Estrogen Receptor Beta Sale Market Share by Application (2017-2022)
2.5.2 Global Estrogen Receptor Beta Revenue and Market Share by Application (2017-2022)
2.5.3 Global Estrogen Receptor Beta Sale Price by Application (2017-2022)
3 Global Estrogen Receptor Beta by Company
3.1 Global Estrogen Receptor Beta Breakdown Data by Company
3.1.1 Global Estrogen Receptor Beta Annual Sales by Company (2020-2022)
3.1.2 Global Estrogen Receptor Beta Sales Market Share by Company (2020-2022)
3.2 Global Estrogen Receptor Beta Annual Revenue by Company (2020-2022)
3.2.1 Global Estrogen Receptor Beta Revenue by Company (2020-2022)
3.2.2 Global Estrogen Receptor Beta Revenue Market Share by Company (2020-2022)
3.3 Global Estrogen Receptor Beta Sale Price by Company
3.4 Key Manufacturers Estrogen Receptor Beta Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Estrogen Receptor Beta Product Location Distribution
3.4.2 Players Estrogen Receptor Beta Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Estrogen Receptor Beta by Geographic Region
4.1 World Historic Estrogen Receptor Beta Market Size by Geographic Region (2017-2022)
4.1.1 Global Estrogen Receptor Beta Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Estrogen Receptor Beta Annual Revenue by Geographic Region
4.2 World Historic Estrogen Receptor Beta Market Size by Country/Region (2017-2022)
4.2.1 Global Estrogen Receptor Beta Annual Sales by Country/Region (2017-2022)
4.2.2 Global Estrogen Receptor Beta Annual Revenue by Country/Region
4.3 Americas Estrogen Receptor Beta Sales Growth
4.4 APAC Estrogen Receptor Beta Sales Growth
4.5 Europe Estrogen Receptor Beta Sales Growth
4.6 Middle East & Africa Estrogen Receptor Beta Sales Growth
5 Americas
5.1 Americas Estrogen Receptor Beta Sales by Country
5.1.1 Americas Estrogen Receptor Beta Sales by Country (2017-2022)
5.1.2 Americas Estrogen Receptor Beta Revenue by Country (2017-2022)
5.2 Americas Estrogen Receptor Beta Sales by Type
5.3 Americas Estrogen Receptor Beta Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Estrogen Receptor Beta Sales by Region
6.1.1 APAC Estrogen Receptor Beta Sales by Region (2017-2022)
6.1.2 APAC Estrogen Receptor Beta Revenue by Region (2017-2022)
6.2 APAC Estrogen Receptor Beta Sales by Type
6.3 APAC Estrogen Receptor Beta Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Estrogen Receptor Beta by Country
7.1.1 Europe Estrogen Receptor Beta Sales by Country (2017-2022)
7.1.2 Europe Estrogen Receptor Beta Revenue by Country (2017-2022)
7.2 Europe Estrogen Receptor Beta Sales by Type
7.3 Europe Estrogen Receptor Beta Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Estrogen Receptor Beta by Country
8.1.1 Middle East & Africa Estrogen Receptor Beta Sales by Country (2017-2022)
8.1.2 Middle East & Africa Estrogen Receptor Beta Revenue by Country (2017-2022)
8.2 Middle East & Africa Estrogen Receptor Beta Sales by Type
8.3 Middle East & Africa Estrogen Receptor Beta Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Estrogen Receptor Beta
10.3 Manufacturing Process Analysis of Estrogen Receptor Beta
10.4 Industry Chain Structure of Estrogen Receptor Beta
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Estrogen Receptor Beta Distributors
11.3 Estrogen Receptor Beta Customer
12 World Forecast Review for Estrogen Receptor Beta by Geographic Region
12.1 Global Estrogen Receptor Beta Market Size Forecast by Region
12.1.1 Global Estrogen Receptor Beta Forecast by Region (2023-2028)
12.1.2 Global Estrogen Receptor Beta Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Estrogen Receptor Beta Forecast by Type
12.7 Global Estrogen Receptor Beta Forecast by Application
13 Key Players Analysis
13.1 Acadia Pharmaceuticals Inc
13.1.1 Acadia Pharmaceuticals Inc Company Information
13.1.2 Acadia Pharmaceuticals Inc Estrogen Receptor Beta Product Offered
13.1.3 Acadia Pharmaceuticals Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Acadia Pharmaceuticals Inc Main Business Overview
13.1.5 Acadia Pharmaceuticals Inc Latest Developments
13.2 AstraZeneca Plc
13.2.1 AstraZeneca Plc Company Information
13.2.2 AstraZeneca Plc Estrogen Receptor Beta Product Offered
13.2.3 AstraZeneca Plc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Plc Main Business Overview
13.2.5 AstraZeneca Plc Latest Developments
13.3 Atossa Genetics Inc
13.3.1 Atossa Genetics Inc Company Information
13.3.2 Atossa Genetics Inc Estrogen Receptor Beta Product Offered
13.3.3 Atossa Genetics Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Atossa Genetics Inc Main Business Overview
13.3.5 Atossa Genetics Inc Latest Developments
13.4 Chamaeleo Pharma NV
13.4.1 Chamaeleo Pharma NV Company Information
13.4.2 Chamaeleo Pharma NV Estrogen Receptor Beta Product Offered
13.4.3 Chamaeleo Pharma NV Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Chamaeleo Pharma NV Main Business Overview
13.4.5 Chamaeleo Pharma NV Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Estrogen Receptor Beta Product Offered
13.5.3 Eli Lilly and Company Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 Endece LLC
13.6.1 Endece LLC Company Information
13.6.2 Endece LLC Estrogen Receptor Beta Product Offered
13.6.3 Endece LLC Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Endece LLC Main Business Overview
13.6.5 Endece LLC Latest Developments
13.7 EndoCeutics Inc
13.7.1 EndoCeutics Inc Company Information
13.7.2 EndoCeutics Inc Estrogen Receptor Beta Product Offered
13.7.3 EndoCeutics Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 EndoCeutics Inc Main Business Overview
13.7.5 EndoCeutics Inc Latest Developments
13.8 Karo Pharma AB
13.8.1 Karo Pharma AB Company Information
13.8.2 Karo Pharma AB Estrogen Receptor Beta Product Offered
13.8.3 Karo Pharma AB Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Karo Pharma AB Main Business Overview
13.8.5 Karo Pharma AB Latest Developments
13.9 Kissei Pharmaceutical Co Ltd
13.9.1 Kissei Pharmaceutical Co Ltd Company Information
13.9.2 Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Product Offered
13.9.3 Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kissei Pharmaceutical Co Ltd Main Business Overview
13.9.5 Kissei Pharmaceutical Co Ltd Latest Developments
13.10 MEI Pharma Inc
13.10.1 MEI Pharma Inc Company Information
13.10.2 MEI Pharma Inc Estrogen Receptor Beta Product Offered
13.10.3 MEI Pharma Inc Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 MEI Pharma Inc Main Business Overview
13.10.5 MEI Pharma Inc Latest Developments
13.11 Mithra Pharmaceuticals SA
13.11.1 Mithra Pharmaceuticals SA Company Information
13.11.2 Mithra Pharmaceuticals SA Estrogen Receptor Beta Product Offered
13.11.3 Mithra Pharmaceuticals SA Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Mithra Pharmaceuticals SA Main Business Overview
13.11.5 Mithra Pharmaceuticals SA Latest Developments
13.12 Oasmia Pharmaceutical AB
13.12.1 Oasmia Pharmaceutical AB Company Information
13.12.2 Oasmia Pharmaceutical AB Estrogen Receptor Beta Product Offered
13.12.3 Oasmia Pharmaceutical AB Estrogen Receptor Beta Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Oasmia Pharmaceutical AB Main Business Overview
13.12.5 Oasmia Pharmaceutical AB Latest Developments
14 Research Findings and Conclusion
Table 1. Estrogen Receptor Beta Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Estrogen Receptor Beta Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Erteberel
Table 4. Major Players of Estetrol
Table 5. Major Players of Fosfestrol
Table 6. Major Players of Fulvestrant
Table 7. Major Players of Others
Table 8. Global Estrogen Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Estrogen Receptor Beta Sales Market Share by Type (2017-2022)
Table 10. Global Estrogen Receptor Beta Revenue by Type (2017-2022) & ($ million)
Table 11. Global Estrogen Receptor Beta Revenue Market Share by Type (2017-2022)
Table 12. Global Estrogen Receptor Beta Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Estrogen Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Estrogen Receptor Beta Sales Market Share by Application (2017-2022)
Table 15. Global Estrogen Receptor Beta Revenue by Application (2017-2022)
Table 16. Global Estrogen Receptor Beta Revenue Market Share by Application (2017-2022)
Table 17. Global Estrogen Receptor Beta Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Estrogen Receptor Beta Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Estrogen Receptor Beta Sales Market Share by Company (2020-2022)
Table 20. Global Estrogen Receptor Beta Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Estrogen Receptor Beta Revenue Market Share by Company (2020-2022)
Table 22. Global Estrogen Receptor Beta Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Estrogen Receptor Beta Producing Area Distribution and Sales Area
Table 24. Players Estrogen Receptor Beta Products Offered
Table 25. Estrogen Receptor Beta Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Estrogen Receptor Beta Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Estrogen Receptor Beta Sales Market Share Geographic Region (2017-2022)
Table 30. Global Estrogen Receptor Beta Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Estrogen Receptor Beta Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Estrogen Receptor Beta Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Estrogen Receptor Beta Sales Market Share by Country/Region (2017-2022)
Table 34. Global Estrogen Receptor Beta Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Estrogen Receptor Beta Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Estrogen Receptor Beta Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Estrogen Receptor Beta Sales Market Share by Country (2017-2022)
Table 38. Americas Estrogen Receptor Beta Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Estrogen Receptor Beta Revenue Market Share by Country (2017-2022)
Table 40. Americas Estrogen Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Estrogen Receptor Beta Sales Market Share by Type (2017-2022)
Table 42. Americas Estrogen Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Estrogen Receptor Beta Sales Market Share by Application (2017-2022)
Table 44. APAC Estrogen Receptor Beta Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Estrogen Receptor Beta Sales Market Share by Region (2017-2022)
Table 46. APAC Estrogen Receptor Beta Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Estrogen Receptor Beta Revenue Market Share by Region (2017-2022)
Table 48. APAC Estrogen Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Estrogen Receptor Beta Sales Market Share by Type (2017-2022)
Table 50. APAC Estrogen Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Estrogen Receptor Beta Sales Market Share by Application (2017-2022)
Table 52. Europe Estrogen Receptor Beta Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Estrogen Receptor Beta Sales Market Share by Country (2017-2022)
Table 54. Europe Estrogen Receptor Beta Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Estrogen Receptor Beta Revenue Market Share by Country (2017-2022)
Table 56. Europe Estrogen Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Estrogen Receptor Beta Sales Market Share by Type (2017-2022)
Table 58. Europe Estrogen Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Estrogen Receptor Beta Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Estrogen Receptor Beta Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Estrogen Receptor Beta Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Estrogen Receptor Beta Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Estrogen Receptor Beta Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Estrogen Receptor Beta Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Estrogen Receptor Beta Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Estrogen Receptor Beta Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Estrogen Receptor Beta Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Estrogen Receptor Beta
Table 69. Key Market Challenges & Risks of Estrogen Receptor Beta
Table 70. Key Industry Trends of Estrogen Receptor Beta
Table 71. Estrogen Receptor Beta Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Estrogen Receptor Beta Distributors List
Table 74. Estrogen Receptor Beta Customer List
Table 75. Global Estrogen Receptor Beta Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Estrogen Receptor Beta Sales Market Forecast by Region
Table 77. Global Estrogen Receptor Beta Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Estrogen Receptor Beta Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Estrogen Receptor Beta Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Estrogen Receptor Beta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Estrogen Receptor Beta Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Estrogen Receptor Beta Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Estrogen Receptor Beta Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Estrogen Receptor Beta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Estrogen Receptor Beta Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Estrogen Receptor Beta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Estrogen Receptor Beta Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Estrogen Receptor Beta Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Estrogen Receptor Beta Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Estrogen Receptor Beta Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Estrogen Receptor Beta Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Estrogen Receptor Beta Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Estrogen Receptor Beta Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Estrogen Receptor Beta Revenue Market Share Forecast by Application (2023-2028)
Table 95. Acadia Pharmaceuticals Inc Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 96. Acadia Pharmaceuticals Inc Estrogen Receptor Beta Product Offered
Table 97. Acadia Pharmaceuticals Inc Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Acadia Pharmaceuticals Inc Main Business
Table 99. Acadia Pharmaceuticals Inc Latest Developments
Table 100. AstraZeneca Plc Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 101. AstraZeneca Plc Estrogen Receptor Beta Product Offered
Table 102. AstraZeneca Plc Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. AstraZeneca Plc Main Business
Table 104. AstraZeneca Plc Latest Developments
Table 105. Atossa Genetics Inc Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 106. Atossa Genetics Inc Estrogen Receptor Beta Product Offered
Table 107. Atossa Genetics Inc Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Atossa Genetics Inc Main Business
Table 109. Atossa Genetics Inc Latest Developments
Table 110. Chamaeleo Pharma NV Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 111. Chamaeleo Pharma NV Estrogen Receptor Beta Product Offered
Table 112. Chamaeleo Pharma NV Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Chamaeleo Pharma NV Main Business
Table 114. Chamaeleo Pharma NV Latest Developments
Table 115. Eli Lilly and Company Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 116. Eli Lilly and Company Estrogen Receptor Beta Product Offered
Table 117. Eli Lilly and Company Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Eli Lilly and Company Main Business
Table 119. Eli Lilly and Company Latest Developments
Table 120. Endece LLC Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 121. Endece LLC Estrogen Receptor Beta Product Offered
Table 122. Endece LLC Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Endece LLC Main Business
Table 124. Endece LLC Latest Developments
Table 125. EndoCeutics Inc Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 126. EndoCeutics Inc Estrogen Receptor Beta Product Offered
Table 127. EndoCeutics Inc Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. EndoCeutics Inc Main Business
Table 129. EndoCeutics Inc Latest Developments
Table 130. Karo Pharma AB Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 131. Karo Pharma AB Estrogen Receptor Beta Product Offered
Table 132. Karo Pharma AB Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Karo Pharma AB Main Business
Table 134. Karo Pharma AB Latest Developments
Table 135. Kissei Pharmaceutical Co Ltd Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 136. Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Product Offered
Table 137. Kissei Pharmaceutical Co Ltd Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Kissei Pharmaceutical Co Ltd Main Business
Table 139. Kissei Pharmaceutical Co Ltd Latest Developments
Table 140. MEI Pharma Inc Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 141. MEI Pharma Inc Estrogen Receptor Beta Product Offered
Table 142. MEI Pharma Inc Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. MEI Pharma Inc Main Business
Table 144. MEI Pharma Inc Latest Developments
Table 145. Mithra Pharmaceuticals SA Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 146. Mithra Pharmaceuticals SA Estrogen Receptor Beta Product Offered
Table 147. Mithra Pharmaceuticals SA Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Mithra Pharmaceuticals SA Main Business
Table 149. Mithra Pharmaceuticals SA Latest Developments
Table 150. Oasmia Pharmaceutical AB Basic Information, Estrogen Receptor Beta Manufacturing Base, Sales Area and Its Competitors
Table 151. Oasmia Pharmaceutical AB Estrogen Receptor Beta Product Offered
Table 152. Oasmia Pharmaceutical AB Estrogen Receptor Beta Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Oasmia Pharmaceutical AB Main Business
Table 154. Oasmia Pharmaceutical AB Latest Developments
List of Figures
Figure 1. Picture of Estrogen Receptor Beta
Figure 2. Estrogen Receptor Beta Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Estrogen Receptor Beta Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Estrogen Receptor Beta Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Estrogen Receptor Beta Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Erteberel
Figure 10. Product Picture of Estetrol
Figure 11. Product Picture of Fosfestrol
Figure 12. Product Picture of Fulvestrant
Figure 13. Product Picture of Others
Figure 14. Global Estrogen Receptor Beta Sales Market Share by Type in 2021
Figure 15. Global Estrogen Receptor Beta Revenue Market Share by Type (2017-2022)
Figure 16. Estrogen Receptor Beta Consumed in Women's Health
Figure 17. Global Estrogen Receptor Beta Market: Women's Health (2017-2022) & (K Pcs)
Figure 18. Estrogen Receptor Beta Consumed in Metabolic Disorder
Figure 19. Global Estrogen Receptor Beta Market: Metabolic Disorder (2017-2022) & (K Pcs)
Figure 20. Estrogen Receptor Beta Consumed in Dermatology
Figure 21. Global Estrogen Receptor Beta Market: Dermatology (2017-2022) & (K Pcs)
Figure 22. Estrogen Receptor Beta Consumed in Immunology
Figure 23. Global Estrogen Receptor Beta Market: Immunology (2017-2022) & (K Pcs)
Figure 24. Estrogen Receptor Beta Consumed in Others
Figure 25. Global Estrogen Receptor Beta Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Estrogen Receptor Beta Sales Market Share by Application (2017-2022)
Figure 27. Global Estrogen Receptor Beta Revenue Market Share by Application in 2021
Figure 28. Estrogen Receptor Beta Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Estrogen Receptor Beta Revenue Market Share by Company in 2021
Figure 30. Global Estrogen Receptor Beta Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Estrogen Receptor Beta Revenue Market Share by Geographic Region in 2021
Figure 32. Global Estrogen Receptor Beta Sales Market Share by Region (2017-2022)
Figure 33. Global Estrogen Receptor Beta Revenue Market Share by Country/Region in 2021
Figure 34. Americas Estrogen Receptor Beta Sales 2017-2022 (K Pcs)
Figure 35. Americas Estrogen Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 36. APAC Estrogen Receptor Beta Sales 2017-2022 (K Pcs)
Figure 37. APAC Estrogen Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 38. Europe Estrogen Receptor Beta Sales 2017-2022 (K Pcs)
Figure 39. Europe Estrogen Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Estrogen Receptor Beta Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Estrogen Receptor Beta Revenue 2017-2022 ($ Millions)
Figure 42. Americas Estrogen Receptor Beta Sales Market Share by Country in 2021
Figure 43. Americas Estrogen Receptor Beta Revenue Market Share by Country in 2021
Figure 44. United States Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Estrogen Receptor Beta Sales Market Share by Region in 2021
Figure 49. APAC Estrogen Receptor Beta Revenue Market Share by Regions in 2021
Figure 50. China Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Estrogen Receptor Beta Sales Market Share by Country in 2021
Figure 57. Europe Estrogen Receptor Beta Revenue Market Share by Country in 2021
Figure 58. Germany Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Estrogen Receptor Beta Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Estrogen Receptor Beta Revenue Market Share by Country in 2021
Figure 65. Egypt Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Estrogen Receptor Beta Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Estrogen Receptor Beta in 2021
Figure 71. Manufacturing Process Analysis of Estrogen Receptor Beta
Figure 72. Industry Chain Structure of Estrogen Receptor Beta
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...